Browse by Series:

FDA Approval in Rare Leukemias, Priority Reviews in MSI-H Cancers and Merkel Cell Carcinoma, and More

Gina Columbus
Published: Thursday, Dec 01, 2016

SELECTED
LANGUAGE
Slider Left
Slider Right
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Oncology Best Practice™ Decision Points in Advanced NSCLC: Assessing Treatment Options Beyond Disease ProgressionNov 30, 20181.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x